Beleave Commences Trading on the OTCQX Market
Sep 20, 2017 11:00 am UTC| Business
TORONTO, Sept. 20, 2017 -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that effective immediately its common shares have been approved for trading on OTCQX®, the highest tier...
Edge Therapeutics to Present at Upcoming Investor Conferences
Sep 20, 2017 11:00 am UTC| Business
BERKELEY HEIGHTS, N.J., Sept. 20, 2017 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life-threatening conditions,...
Stemline Therapeutics to Present at Upcoming Investor Conferences
Sep 20, 2017 11:00 am UTC| Business
NEW YORK, Sept. 20, 2017 -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced that Ivan Bergstein, M.D.,...
New York Media Festival Returns to Manhattan with 15+ Events and 200+ Speakers, September 26-27
Sep 20, 2017 11:00 am UTC| Business
NEW YORK, Sept. 20, 2017 -- New York Media Festival, an innovative two-day event for the digital, games, music, television and video industries, will take place Tuesday, September 26, through Wednesday, September 27,...
Seasoned Software Investors Establish Elsewhere Partners to Focus on “Outliers”
Sep 20, 2017 11:00 am UTC| Business
AUSTIN, Texas, Sept. 20, 2017 -- Veteran software investors Chris Pacitti, John Thornton and Sam Kentor today launched Elsewhere Partners, a growth-stage venture capital firm. Elsewhere Partners invests exclusively in...
Knomatic and I2oT Solutions Announce One Year Anniversary of Technology Partnership
Sep 20, 2017 11:00 am UTC| Business
HOUSTON, Sept. 20, 2017 -- Knomatic, the leader in enterprise mobility, business workflow and process solutions, today announced that they have successfully collaborated with technology partner I²oT Solutions for the...
AGTC to Present at Upcoming Conferences
Sep 20, 2017 11:00 am UTC| Business
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 20, 2017 -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene...